NO952411L - Midler for behandling av metaboliske bensykdommer - Google Patents

Midler for behandling av metaboliske bensykdommer

Info

Publication number
NO952411L
NO952411L NO952411A NO952411A NO952411L NO 952411 L NO952411 L NO 952411L NO 952411 A NO952411 A NO 952411A NO 952411 A NO952411 A NO 952411A NO 952411 L NO952411 L NO 952411L
Authority
NO
Norway
Prior art keywords
treatment
metabolic bone
bone disorders
bone diseases
metabolic
Prior art date
Application number
NO952411A
Other languages
English (en)
Norwegian (no)
Other versions
NO952411D0 (no
Inventor
Masakazu Katoh
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO952411D0 publication Critical patent/NO952411D0/no
Publication of NO952411L publication Critical patent/NO952411L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO952411A 1994-06-17 1995-06-16 Midler for behandling av metaboliske bensykdommer NO952411L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6135275A JPH083058A (ja) 1994-06-17 1994-06-17 新規な骨代謝疾患治療剤

Publications (2)

Publication Number Publication Date
NO952411D0 NO952411D0 (no) 1995-06-16
NO952411L true NO952411L (no) 1995-12-18

Family

ID=15147903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952411A NO952411L (no) 1994-06-17 1995-06-16 Midler for behandling av metaboliske bensykdommer

Country Status (10)

Country Link
US (1) US5726148A (hu)
EP (1) EP0687470A3 (hu)
JP (1) JPH083058A (hu)
KR (1) KR960000248A (hu)
AU (1) AU697136B2 (hu)
CA (1) CA2152023A1 (hu)
FI (1) FI952953A (hu)
HU (1) HU218947B (hu)
NO (1) NO952411L (hu)
TW (1) TW496740B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US7029861B1 (en) 1998-09-15 2006-04-18 Board Of Regents, The University Of Texas System LPS-response gene compositions and methods
JP3755564B2 (ja) 1999-05-24 2006-03-15 株式会社村田製作所 圧電共振部品及びその製造方法
CA2378880C (en) 1999-07-21 2010-02-23 Omeros Medical Systems, Inc. Solutions and methods for inhibition of pain, inflammation and cartilage degradation
WO2002066063A1 (fr) * 2001-02-23 2002-08-29 Nippon Organon K.K. Traitements de maladies osseuses metaboliques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) * 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
AU6030990A (en) * 1989-07-07 1991-02-06 E.I. Du Pont De Nemours And Company Soluble human b-cell interleukin-1 receptor
EP0474141B1 (en) * 1990-09-03 1996-01-31 Kuraray Co., Ltd. Peptide or its salts
CA2098848A1 (en) * 1990-12-20 1992-06-21 Joseph C. Glorioso Truncated interleukin-1 receptor gene for the treatment of arthritis

Also Published As

Publication number Publication date
HU9501779D0 (en) 1995-08-28
TW496740B (en) 2002-08-01
EP0687470A3 (en) 1996-06-19
US5726148A (en) 1998-03-10
FI952953A (fi) 1995-12-18
FI952953A0 (fi) 1995-06-15
HU218947B (hu) 2001-01-29
NO952411D0 (no) 1995-06-16
EP0687470A2 (en) 1995-12-20
AU697136B2 (en) 1998-09-24
AU2171695A (en) 1996-01-04
KR960000248A (ko) 1996-01-25
CA2152023A1 (en) 1995-12-18
JPH083058A (ja) 1996-01-09
HUT72054A (en) 1996-03-28

Similar Documents

Publication Publication Date Title
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
GB0222495D0 (en) Compounds
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
NO20073615L (no) 3, 5-disubstituert og 3, 5, 7-trisubstituert-3H-oksazolo og 3H-tiazolo [4,5-d]pyrimidin-2-on forbindelser og prodrug derav
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ATE302606T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
HUP0203590A2 (hu) Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
DE69814394D1 (de) Verwendung von levobupivacain
DE69725879D1 (de) VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
AU2003260436A1 (en) Pyrimidine compounds
NO952411L (no) Midler for behandling av metaboliske bensykdommer
TR199700956T1 (xx) Indazolkarboksamidler.
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
HK1061209A1 (en) Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application